References
- Düsterberg B., Beier S., Schneider W. H. F., Spona J. Pharmacological features of gestodene in laboratory animals and man. Gestodene, a New Direction in Oral Contraception, M. Breckwoldt, B. Düsterberg. Parthenon Publishing, CarnforthUK 1988; 13–29
- Brill K., Norpoth T., Schnitker J., Albring M. Clinical experience with a low-dose oral contraceptive in almost 100,000 users. Contraception 1991; 43: 101–10
- Latin American Oral Contraceptive Study Group. Clinical comparison of monophasic oral contraceptive preparations of gestodene/ethinylestradiol and desogestrel/ethinylestradiol. Contraception 1994; 50: 201–14
- Rosenberg M.J., Long S.C. Oral contraceptives and cycle control: a critical review of the literature. Contraception 1992; 8(Suppl. 1)35
- Yuzpe A.A. Triphasic levonorgestrel: its role in oral contraception. Gynecol. Endocrinol. 1995; 9(Suppl. 2)29–37
- Rosenberg M.J., Waugh M.S., Meehan T.E. Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation. Contraception 1995; 51: 283–8